TreeWAS – Variant ID: rs17645023

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C90.2 Plasmacytoma, extramedullary	0.000	0.974	0.026
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.975	0.025
C90.0 Multiple myeloma	0.000	0.976	0.024
K63.8 Other specified diseases of intestine	0.020	0.980	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.981	0.019
C83.3 Large cell (diffuse)	0.000	0.981	0.019
C90.3 Solitary plasmacytoma	0.000	0.981	0.019
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.981	0.019
C90.1 Plasma cell leukaemia	0.000	0.983	0.017
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.983	0.017
C92 Myeloid leukaemia	0.000	0.983	0.017
A08.4 Viral intestinal infection, unspecified	0.000	0.984	0.016
C92.1 Chronic myeloid leukaemia	0.000	0.984	0.016
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.984	0.016
C91 Lymphoid leukaemia	0.000	0.985	0.015
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.985	0.015
C84.4 Peripheral T-cell lymphoma	0.000	0.985	0.015
C91.0 Acute lymphoblastic leukaemia	0.000	0.986	0.014
C95 Leukaemia of unspecified cell type	0.000	0.986	0.014
C84.0 Mycosis fungoides	0.000	0.986	0.014
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.986	0.014
C94 Other leukaemias of specified cell type	0.000	0.986	0.014
C86 Other specified types of T/NK-cell lymphoma	0.000	0.986	0.014
C83.7 Burkitt's tumour	0.000	0.986	0.014
C83.6 Undifferentiated (diffuse)	0.000	0.986	0.014
C83.5 Lymphoblastic (diffuse)	0.000	0.986	0.014
C83.4 Immunoblastic (diffuse)	0.000	0.986	0.014
C83.2 Mixed small and large cell (diffuse)	0.000	0.986	0.014
R23.2 Flushing	0.000	0.986	0.014
C88 Malignant immunoproliferative diseases	0.000	0.987	0.013
C92.4 Acute promyelocytic leukaemia	0.000	0.987	0.013
C84.5 Other and unspecified T-cell lymphomas	0.000	0.987	0.013
C93 Monocytic leukaemia	0.000	0.987	0.013
N20.1 Calculus of ureter	0.013	0.987	0.000
C83.1 Small cleaved cell (diffuse)	0.000	0.987	0.013
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.987	0.013
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.987	0.013
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.987	0.013
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.987	0.013
C84.3 Lymphoepithelioid lymphoma	0.000	0.987	0.013
C84.2 T-zone lymphoma	0.000	0.987	0.013
C84.1 Sezary's diease	0.000	0.987	0.013
Z91.0 Personal history of allergy, other than to drugs and biological substances	0.000	0.988	0.012
C92.9 Myeloid leukaemia, unspecified	0.000	0.988	0.012
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.988	0.012
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.988	0.012
C92.3 Myeloid sarcoma	0.000	0.988	0.012
C92.2 Subacute myeloid leukaemia	0.000	0.988	0.012
C91.4 Hairy-cell leukaemia	0.000	0.988	0.012
C81 Hodgkin's disease	0.000	0.988	0.012
C92.7 Other myeloid leukaemia	0.000	0.988	0.012
R23 Other skin changes	0.000	0.988	0.012
R23.3 Spontaneous ecchymoses	0.000	0.988	0.012
C43.6 Malignant melanoma of upper limb, including shoulder	0.012	0.988	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.989	0.011
C91.7 Other lymphoid leukaemia	0.000	0.989	0.011
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.989	0.011
C91.5 Adult T-cell leukaemia	0.000	0.989	0.011
C91.3 Prolymphocytic leukaemia	0.000	0.989	0.011
C91.2 Subacute lymphocytic leukaemia	0.000	0.989	0.011
C92.5 Acute myelomonocytic leukaemia	0.000	0.989	0.011
J69.0 Pneumonitis due to food and vomit	0.011	0.989	0.000
C95.9 Leukaemia, unspecified	0.000	0.989	0.011
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.989	0.011
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.989	0.011
R23.8 Other and unspecified skin changes	0.000	0.989	0.011
C95.7 Other leukaemia of unspecified cell type	0.000	0.989	0.010
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.989	0.010
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.989	0.010
C95.0 Acute leukaemia of unspecified cell type	0.000	0.989	0.010
C91.9 Lymphoid leukaemia, unspecified	0.000	0.990	0.010
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.990	0.010
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.990	0.010
C86.4 Blastic NK-cell lymphoma	0.000	0.990	0.010
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.990	0.010
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.990	0.010
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.990	0.010
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.990	0.010
C94.7 Other specified leukaemias	0.000	0.990	0.010
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.990	0.010
C94.5 Acute myelofibrosis	0.000	0.990	0.010
C94.4 Acute panmyelosis	0.000	0.990	0.010
C94.3 Mast cell leukaemia	0.000	0.990	0.010
C94.2 Acute megakaryoblastic leukaemia	0.000	0.990	0.010
C94.1 Chronic erythraemia	0.000	0.990	0.010
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.990	0.010
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.990	0.010
C96.8 Histiocytic sarcoma	0.000	0.990	0.010
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.990	0.010
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.990	0.010
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.990	0.010
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.990	0.010
C96.3 True histiocytic lymphoma	0.000	0.990	0.010
C96.2 Malignant mast cell tumour	0.000	0.990	0.010
C96.1 Malignant histiocytosis	0.000	0.990	0.010
C96.0 Letterer-Siwe disease	0.000	0.990	0.010
R23.4 Changes in skin texture	0.000	0.990	0.010
C92.0 Acute myeloid leukaemia	0.000	0.990	0.010
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.990	0.010
C88.7 Other malignant immunoproliferative diseases	0.000	0.990	0.010
C88.3 Immunoproliferative small intestinal disease	0.000	0.990	0.010
C88.2 Gamma heavy chain disease	0.000	0.990	0.010
C88.1 Alpha heavy chain disease	0.000	0.990	0.010
C81.9 Hodgkin's disease, unspecified	0.000	0.990	0.010
C93.9 Monocytic leukaemia, unspecified	0.000	0.990	0.009
C93.7 Other monocytic leukaemia	0.000	0.990	0.009
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.990	0.009
C93.2 Subacute monocytic leukaemia	0.000	0.990	0.009
C93.0 Acute monocytic leukaemia	0.000	0.990	0.009
I64 Stroke, not specified as haemorrhage or infarction	0.009	0.991	0.000
R23.1 Pallor	0.000	0.991	0.009
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.991	0.009
C81.3 Lymphocytic depletion	0.000	0.991	0.009
C81.2 Mixed cellularity	0.000	0.991	0.009
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.009	0.991	0.000
C82.0 Small cleaved cell, follicular	0.000	0.991	0.009
C82.3 Follicular lymphoma grade IIIa	0.000	0.991	0.009
C93.1 Chronic monocytic leukaemia	0.000	0.991	0.008
C81.7 Other Hodgkin's disease	0.000	0.992	0.008
C81.0 Lymphocytic predominance	0.000	0.992	0.008
X62.9 Unspecified place	0.000	0.992	0.008
C83.0 Small cell (diffuse)	0.000	0.992	0.008
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.992	0.008
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.992	0.008
C82.6 Cutaneous follicle centre lymphoma	0.000	0.992	0.008
C82.5 Diffuse follicle centre lymphoma	0.000	0.992	0.008
C82.4 Follicular lymphoma grade IIIb	0.000	0.992	0.008
C91.1 Chronic lymphocytic leukaemia	0.000	0.992	0.008
C82.2 Large cell, follicular	0.000	0.992	0.007
A08 Viral and other specified intestinal infections	0.000	0.993	0.007
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.007	0.993	0.000
C81.1 Nodular sclerosis	0.000	0.993	0.007
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.993	0.007
J69 Pneumonitis due to solids and liquids	0.007	0.993	0.000
C43 Malignant melanoma of skin	0.006	0.994	0.000
R23.0 Cyanosis	0.000	0.994	0.005
C43.7 Malignant melanoma of lower limb, including hip	0.006	0.994	0.000
N20 Calculus of kidney and ureter	0.006	0.994	0.000
N20.9 Urinary calculus, unspecified	0.006	0.994	0.000
A08.1 Acute gastro-enteropathy due to Norwalk agent	0.000	0.994	0.006
A08.5 Other specified intestinal infections	0.000	0.994	0.005
A08.2 Adenoviral enteritis	0.000	0.994	0.005
A08.0 Rotaviral enteritis	0.000	0.994	0.005
C43.9 Malignant melanoma of skin, unspecified	0.005	0.994	0.000
A08.3 Other viral enteritis	0.000	0.995	0.005
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.995	0.005
S92.00 Fracture of calcaneus (closed)	0.000	0.995	0.005
J69.1 Pneumonitis due to oils and essences	0.005	0.995	0.000
N41.1 Chronic prostatitis	0.005	0.995	0.000
M25.57 Pain in joint (Ankle and foot)	0.000	0.995	0.005
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.005	0.995	0.000
S92.0 Fracture of calcaneus	0.000	0.995	0.005
S92 Fracture of foot, except ankle	0.000	0.995	0.005
J69.8 Pneumonitis due to other solids and liquids	0.005	0.995	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.000	0.995	0.005
S92.20 Fracture of other tarsal bone(s) (closed)	0.000	0.995	0.005
S92.2 Fracture of other tarsal bone(s)	0.000	0.995	0.005
S92.3 Fracture of metatarsal bone	0.000	0.995	0.005
C43.4 Malignant melanoma of scalp and neck	0.005	0.995	0.000
C43.8 Overlapping malignant melanoma of skin	0.004	0.995	0.000
C43.0 Malignant melanoma of lip	0.004	0.995	0.000
N20.2 Calculus of kidney with calculus of ureter	0.004	0.996	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.004	0.996	0.000
K91.3 Postoperative intestinal obstruction	0.004	0.996	0.000
S92.30 Fracture of metatarsal bone (closed)	0.000	0.996	0.004
S92.7 Multiple fractures of foot	0.000	0.996	0.004
S92.1 Fracture of talus	0.000	0.996	0.004
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.996	0.004
C85.0 Lymphosarcoma	0.000	0.996	0.004
S92.70 Multiple fractures of foot (closed)	0.000	0.996	0.004
C43.1 Malignant melanoma of eyelid, including canthus	0.004	0.996	0.000
M77.47 Metatarsalgia-Ankle/Foot	0.004	0.996	0.000
S92.01 Fracture of calcaneus (open)	0.000	0.996	0.004
M77.9 Enthesopathy, unspecified	0.004	0.996	0.000
S92.9 Fracture of foot, unspecified	0.000	0.996	0.004
J60-J70 Lung diseases due to external agents	0.004	0.996	0.000
M22.4 Chondromalacia patellae	0.004	0.996	0.000
J64 Unspecified pneumoconiosis	0.004	0.996	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.996	0.004
X62.0 Home	0.000	0.996	0.004
X62.8 Other specified place	0.000	0.996	0.004
X62.7 Farm	0.000	0.996	0.004
X62.6 Industrial and construction area	0.000	0.996	0.004
X62.5 Trade and service area	0.000	0.996	0.004
X62.4 Street and highway	0.000	0.996	0.004
X62.3 Sports and athletics area	0.000	0.996	0.004
X62.2 School, other institution and public administrative area	0.000	0.996	0.004
X62.1 Residential institution	0.000	0.996	0.004
S92.21 Fracture of other tarsal bone(s) (open)	0.000	0.996	0.004
M77.91 Enthesopathy, unspecified (Shoulder region)	0.004	0.996	0.000
S92.10 Fracture of talus (closed)	0.000	0.996	0.004
L29.0 Pruritus ani	0.000	0.996	0.004
M77.95 Enthesopathy, unspecified (Pelvic region and thigh)	0.004	0.996	0.000
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.000	0.996	0.004
S92.31 Fracture of metatarsal bone (open)	0.000	0.996	0.003
C34.0 Main bronchus	0.000	0.996	0.004
S92.5 Fracture of other toe	0.000	0.996	0.003
H90.5 Sensorineural hearing loss, unspecified	0.000	0.996	0.004
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.996	0.004
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.996	0.003
M77.94 Enthesopathy, unspecified (Hand)	0.003	0.996	0.000
T43.2 Other and unspecified antidepressants	0.000	0.996	0.003
B00.9 Herpesviral infection, unspecified	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
S92.71 Multiple fractures of foot (open)	0.000	0.997	0.003
J62 Pneumoconiosis due to dust containing silica	0.003	0.997	0.000
M77.92 Enthesopathy, unspecified (Upper arm)	0.003	0.997	0.000
T42.1 Iminostilbenes	0.000	0.997	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.003	0.997	0.000
S92.11 Fracture of talus (open)	0.000	0.997	0.003
S64.2 Injury of radial nerve at wrist and hand level	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
M77.96 Enthesopathy, unspecified (Lower leg)	0.003	0.997	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.997	0.003
S92.4 Fracture of great toe	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
J62.8 Pneumoconiosis due to other dust containing silica	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.997	0.003
T42.4 Benzodiazepines	0.000	0.997	0.003
M77.4 Metatarsalgia	0.003	0.997	0.000
M77.99 Enthesopathy, unspecified (Site unspecified)	0.003	0.997	0.000
M77.98 Enthesopathy, unspecified (Other)	0.003	0.997	0.000
M77.93 Enthesopathy, unspecified (Forearm)	0.003	0.997	0.000
M77.90 Enthesopathy, unspecified (Multiple sites)	0.003	0.997	0.000
S92.91 Fracture of foot, unspecified (open)	0.000	0.997	0.003
S92.90 Fracture of foot, unspecified (closed)	0.000	0.997	0.003
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.997	0.003
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours	0.003	0.997	0.000
J66 Airway disease due to specific organic dust	0.003	0.997	0.000
J63 Pneumoconiosis due to other inorganic dusts	0.003	0.997	0.000
J65 Pneumoconiosis associated with tuberculosis	0.003	0.997	0.000
M77.97 Enthesopathy, unspecified (Ankle and foot)	0.003	0.997	0.000
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.000	0.997	0.003
C43.5 Malignant melanoma of trunk	0.003	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
S92.51 Fracture of other toe (open)	0.000	0.997	0.003
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.003	0.997	0.000
S64.4 Injury of digital nerve of other finger	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
S90-S99 Injuries to the ankle and foot	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
J60 Coalworker's pneumoconiosis	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.003
T42.3 Barbiturates	0.000	0.997	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.003
J62.0 Pneumoconiosis due to talc dust	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.000	0.997	0.003
J70 Respiratory conditions due to other external agents	0.003	0.997	0.000
S90 Superficial injury of ankle and foot	0.000	0.997	0.003
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
J67 Hypersensitivity pneumonitis due to organic dust	0.003	0.997	0.000
N80.3 Endometriosis of pelvic peritoneum	0.000	0.997	0.003
T36.0 Penicillins	0.000	0.997	0.003
M23.35 Other meniscus derangements (Posterior horn of lateral meniscus)	0.003	0.997	0.000
M23.3 Other meniscus derangements	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.997	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.000	0.997	0.002
S64 Injury of nerves at wrist and hand level	0.003	0.997	0.000
S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level	0.000	0.997	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.997	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.002
M54.46 Lumbago with sciatica (Lumbar region)	0.000	0.997	0.003
S90.8 Other superficial injuries of ankle and foot	0.000	0.997	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.002
T38.7 Androgens and anabolic congeners	0.000	0.997	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.002
T38.5 Other oestrogens and progestogens	0.000	0.997	0.002
T38.4 Oral contraceptives	0.000	0.997	0.002
T38.2 Antithyroid drugs	0.000	0.997	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.997	0.002
S99 Other and unspecified injuries of ankle and foot	0.000	0.997	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.997	0.002
M77.49 Metatarsalgia-Site unspec	0.002	0.997	0.000
M77.48 Metatarsalgia-Other	0.002	0.997	0.000
M77.46 Metatarsalgia-Lower Leg	0.002	0.997	0.000
M77.45 Metatarsalgia-Pelvic/Thigh	0.002	0.997	0.000
M77.44 Metatarsalgia-Hand	0.002	0.997	0.000
M77.43 Metatarsalgia-Forearm	0.002	0.997	0.000
M77.42 Metatarsalgia-Upper arm	0.002	0.997	0.000
M77.41 Metatarsalgia-Shldr region	0.002	0.997	0.000
M77.40 Metatarsalgia-Mult sites	0.002	0.997	0.000
O30.0 Twin pregnancy	0.002	0.997	0.000
S93.0 Dislocation of ankle joint	0.000	0.998	0.002
J63.8 Pneumoconiosis due to other specified inorganic dusts	0.002	0.998	0.000
J63.5 Stannosis	0.002	0.998	0.000
J63.4 Siderosis	0.002	0.998	0.000
J63.3 Graphite fibrosis (of lung)	0.002	0.998	0.000
J63.2 Berylliosis	0.002	0.998	0.000
J63.1 Bauxite fibrosis (of lung)	0.002	0.998	0.000
J63.0 Aluminosis (of lung)	0.002	0.998	0.000
J66.8 Airway disease due to other specific organic dusts	0.002	0.998	0.000
J66.2 Cannabinosis	0.002	0.998	0.000
J66.1 Flax-dresser's disease	0.002	0.998	0.000
J66.0 Byssinosis	0.002	0.998	0.000
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours	0.002	0.998	0.000
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours	0.002	0.998	0.000
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours	0.002	0.998	0.000
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours	0.002	0.998	0.000
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified	0.002	0.998	0.000
J68.1 Acute pulmonary oedema due to chemicals, gases, fumes and vapours	0.002	0.998	0.000
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours	0.002	0.998	0.000
S90.3 Contusion of other and unspecified parts of foot	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
S64.1 Injury of median nerve at wrist and hand level	0.002	0.998	0.000
M77 Other enthesopathies	0.002	0.998	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.002	0.998	0.000
S92.50 Fracture of other toe (closed)	0.000	0.998	0.002
L29.9 Pruritus, unspecified	0.000	0.998	0.002
T39.1 4-Aminophenol derivatives	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
J67.8 Hypersensitivity pneumonitis due to other organic dusts	0.002	0.998	0.000
M20.6 Acquired deformity of toe(s), unspecified	0.002	0.998	0.000
S97 Crushing injury of ankle and foot	0.000	0.998	0.002
S92.40 Fracture of great toe (closed)	0.000	0.998	0.002
S64.0 Injury of ulnar nerve at wrist and hand level	0.002	0.998	0.000
S98 Traumatic amputation of ankle and foot	0.000	0.998	0.002
S95 Injury of blood vessels at ankle and foot level	0.000	0.998	0.002
S94 Injury of nerves at ankle and foot level	0.000	0.998	0.002
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)	0.002	0.998	0.000
S99.9 Unspecified injury of ankle and foot	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
S90.0 Contusion of ankle	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
M23.31 Other meniscus derangements (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.002	0.998	0.000
S32.50 Fracture of pubis (closed)	0.000	0.998	0.002
S90.9 Superficial injury of ankle and foot, unspecified	0.000	0.998	0.002
X60-X84 Intentional self-harm	0.000	0.998	0.002
J70.9 Respiratory conditions due to unspecified external agent	0.002	0.998	0.000
J70.8 Respiratory conditions due to other specified external agents	0.002	0.998	0.000
J70.4 Drug-induced interstitial lung disorder, unspecified	0.002	0.998	0.000
J70.3 Chronic drug-induced interstitial lung disorders	0.002	0.998	0.000
J70.2 Acute drug-induced interstitial lung disorders	0.002	0.998	0.000
J70.0 Acute pulmonary manifestations due to radiation	0.002	0.998	0.000
S90.7 Multiple superficial injuries of ankle and foot	0.000	0.998	0.002
S90.2 Contusion of toe(s) with damage to nail	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
J67.7 Air-conditioner and humidifier lung	0.002	0.998	0.000
J67.6 Maple-bark-stripper's lung	0.002	0.998	0.000
J67.5 Mushroom-worker's lung	0.002	0.998	0.000
J67.4 Maltworker's lung	0.002	0.998	0.000
J67.3 Suberosis	0.002	0.998	0.000
J67.1 Bagassosis	0.002	0.998	0.000
J67.0 Farmer's lung	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
M23.37 Other meniscus derangements-Capsular lig	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
S92.41 Fracture of great toe (open)	0.000	0.998	0.002
M77.3 Calcaneal spur	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
C43.3 Malignant melanoma of other and unspecified parts of face	0.002	0.998	0.000
M23.30 Other meniscus derangements (Multiple sites)	0.002	0.998	0.000
S64.9 Injury of unspecified nerve at wrist and hand level	0.002	0.998	0.000
S64.8 Injury of other nerves at wrist and hand level	0.002	0.998	0.000
S64.7 Injury of multiple nerves at wrist and hand level	0.002	0.998	0.000
S93.4 Sprain and strain of ankle	0.000	0.998	0.002
S93.6 Sprain and strain of other and unspecified parts of foot	0.000	0.998	0.002
S93.5 Sprain and strain of toe(s)	0.000	0.998	0.002
S93.2 Rupture of ligaments at ankle and foot level	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
M62.89 Other specified disorders of muscle (Site unspecified)	0.002	0.998	0.000
L57 Skin changes due to chronic exposure to nonionising radiation	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
S90.1 Contusion of toe(s) without damage to nail	0.000	0.998	0.002
S93.3 Dislocation of other and unspecified parts of foot	0.000	0.998	0.002
S99.7 Multiple injuries of ankle and foot	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
S93.1 Dislocation of toe(s)	0.000	0.998	0.002
S99.8 Other specified injuries of ankle and foot	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
M62.8 Other specified disorders of muscle	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
M77.8 Other enthesopathies, not elsewhere classified	0.002	0.998	0.000
M77.2 Periarthritis of wrist	0.002	0.998	0.000
L29 Pruritus	0.000	0.998	0.002
M77.37 Calcaneal spur-Ankle/Foot	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.000	0.998	0.002
D68.5 Primary Thrombophilia	0.002	0.998	0.000
J67.2 Bird fancier's lung	0.002	0.998	0.000
S97.8 Crushing injury of other parts of ankle and foot	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
C85.1 B-cell lymphoma, unspecified	0.000	0.998	0.002
S97.1 Crushing injury of toe(s)	0.000	0.998	0.002
S97.0 Crushing injury of ankle	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
X60.8 Other specified place	0.000	0.998	0.002
X68 Intentional self-poisoning by and exposure to pesticides	0.000	0.998	0.002
J70.1 Chronic and other pulmonary manifestations due to radiation	0.002	0.998	0.000
S94.9 Injury of unspecified nerve at ankle and foot level	0.000	0.998	0.002
S94.8 Injury of other nerves at ankle and foot level	0.000	0.998	0.002
S94.7 Injury of multiple nerves at ankle and foot level	0.000	0.998	0.002
S94.3 Injury of cutaneous sensory nerve at ankle and foot level	0.000	0.998	0.002
S94.2 Injury of deep peroneal nerve at ankle and foot level	0.000	0.998	0.002
S94.1 Injury of medial plantar nerve	0.000	0.998	0.002
S94.0 Injury of lateral plantar nerve	0.000	0.998	0.002
S95.9 Injury of unspecified blood vessel at ankle and foot level	0.000	0.998	0.002
S95.8 Injury of other blood vessels at ankle and foot level	0.000	0.998	0.002
S95.7 Injury of multiple blood vessels at ankle and foot level	0.000	0.998	0.002
S95.2 Injury of dorsal vein of foot	0.000	0.998	0.002
S95.1 Injury of plantar artery of foot	0.000	0.998	0.002
S95.0 Injury of dorsal artery of foot	0.000	0.998	0.002
S98.4 Traumatic amputation of foot, level unspecified	0.000	0.998	0.002
S98.3 Traumatic amputation of other parts of foot	0.000	0.998	0.002
S98.2 Traumatic amputation of two or more toes	0.000	0.998	0.002
S98.1 Traumatic amputation of one toe	0.000	0.998	0.002
S98.0 Traumatic amputation of foot at ankle level	0.000	0.998	0.002
S96 Injury of muscle and tendon at ankle and foot level	0.000	0.998	0.002
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.002	0.998	0.000
M62.80 Other specified disorders of muscle (Multiple sites)	0.002	0.998	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
X84 Intentional self-harm by unspecified means	0.000	0.998	0.002
X83 Intentional self-harm by other specified means	0.000	0.998	0.002
X82 Intentional self-harm by crashing of motor vehicle	0.000	0.998	0.002
X81 Intentional self-harm by jumping or lying before moving object	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations